140 related articles for article (PubMed ID: 32932265)
21. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
J Am Acad Dermatol; 2005 Aug; 53(2):253-60. PubMed ID: 16021120
[TBL] [Abstract][Full Text] [Related]
22. Skin substitutes for the management of mohs micrographic surgery wounds: a systematic review.
Lu KW; Khachemoune A
Arch Dermatol Res; 2023 Jan; 315(1):17-31. PubMed ID: 35169876
[TBL] [Abstract][Full Text] [Related]
23. Mohs Micrographic Surgery.
Wong E; Axibal E; Brown M
Facial Plast Surg Clin North Am; 2019 Feb; 27(1):15-34. PubMed ID: 30420068
[TBL] [Abstract][Full Text] [Related]
24. [MOHS MICROGRAPHIC SURGERY FOR CUTANEOUS MALIGNANT LESIONS EXCISION: EXPERIENCE OF A SINGLE TERTIARY MEDICAL CENTER IN ISRAEL].
Winder G; Haik J; Harats M; Avinoam-Dar G
Harefuah; 2020 Aug; 159(8):554-559. PubMed ID: 32852153
[TBL] [Abstract][Full Text] [Related]
25. The role of teledermatology in Mohs micrographic surgery: a review.
Algarin YA; Jaalouk D; Pulumati A; Nouri K
Arch Dermatol Res; 2024 Apr; 316(5):119. PubMed ID: 38625403
[TBL] [Abstract][Full Text] [Related]
26. Mohs micrographic surgery for dermatofibrosarcoma protuberans: University of Miami and NYU experience.
Nouri K; Lodha R; Jimenez G; Robins P
Dermatol Surg; 2002 Nov; 28(11):1060-4; discussion 1064. PubMed ID: 12460303
[TBL] [Abstract][Full Text] [Related]
27. Tissue-Sparing Outcome of Mohs Micrographic Surgery in Squamous Cell Carcinomas.
Correa J; Pastor M; Céspedes E; Magliano J; Bazzano C
Actas Dermosifiliogr (Engl Ed); 2020 Dec; 111(10):847-851. PubMed ID: 32717186
[TBL] [Abstract][Full Text] [Related]
28. Superficial leiomyosarcoma treated with Mohs micrographic surgery.
Humphreys TR; Finkelstein DH; Lee JB
Dermatol Surg; 2004 Jan; 30(1):108-12. PubMed ID: 14692939
[TBL] [Abstract][Full Text] [Related]
29. Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria.
Stuart SE; Schoen P; Jin C; Parvataneni R; Arron S; Linos E; Boscardin WJ; Chren MM
J Am Acad Dermatol; 2017 Jun; 76(6):1131-1138.e1. PubMed ID: 28365039
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of mohs microgrpahic resection for cutaneous malignancy involving the scrotum.
Roberson D; Chelluri R; Skokan AJ; Xia L; Heavner MG; Lukowiak T; Schwartz L; Lee DJ; Guzzo TJ; Kovach SJ; Miller C; Kovell RC
Urol Oncol; 2021 Aug; 39(8):501.e11-501.e16. PubMed ID: 34187750
[TBL] [Abstract][Full Text] [Related]
31. Understanding Mohs Micrographic Surgery: A Review and Practical Guide for the Nondermatologist.
Tolkachjov SN; Brodland DG; Coldiron BM; Fazio MJ; Hruza GJ; Roenigk RK; Rogers HW; Zitelli JA; Winchester DS; Harmon CB
Mayo Clin Proc; 2017 Aug; 92(8):1261-1271. PubMed ID: 28778259
[TBL] [Abstract][Full Text] [Related]
32. A 4-year retrospective assessment of postoperative complications in immunosuppressed patients following Mohs micrographic surgery.
Basu P; Goldenberg A; Cowan N; Eilers R; Hau J; Jiang SIB
J Am Acad Dermatol; 2019 Jun; 80(6):1594-1601. PubMed ID: 30502411
[TBL] [Abstract][Full Text] [Related]
33. Factors predicting outcomes of patients with high-risk squamous cell carcinoma treated with Mohs micrographic surgery.
Matsumoto A; Li JN; Matsumoto M; Pineider J; Nijhawan RI; Srivastava D
J Am Acad Dermatol; 2021 Sep; 85(3):588-595. PubMed ID: 33524409
[TBL] [Abstract][Full Text] [Related]
34. Mohs micrographic surgery for the treatment of primary cutaneous melanoma.
Zitelli JA; Brown C; Hanusa BH
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):236-45. PubMed ID: 9270510
[TBL] [Abstract][Full Text] [Related]
35. Mohs micrographic surgery for eccrine porocarcinoma: an update and review of the literature.
Song SS; Wu Lee W; Hamman MS; Jiang SI
Dermatol Surg; 2015 Mar; 41(3):301-6. PubMed ID: 25742554
[TBL] [Abstract][Full Text] [Related]
36. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
[TBL] [Abstract][Full Text] [Related]
37. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
38. A Comparison of Mohs Micrographic Surgery and Wide Local Excision for Treatment of Dermatofibrosarcoma Protuberans With Long-Term Follow-up: The Mayo Clinic Experience.
Lowe GC; Onajin O; Baum CL; Otley CC; Arpey CJ; Roenigk RK; Brewer JD
Dermatol Surg; 2017 Jan; 43(1):98-106. PubMed ID: 27749444
[TBL] [Abstract][Full Text] [Related]
39. Dermatofibrosarcoma protuberans treated with Mohs micrographic surgery: cure rates and surgical margins.
Dawes KW; Hanke CW
Dermatol Surg; 1996 Jun; 22(6):530-4. PubMed ID: 8646467
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
J Am Acad Dermatol; 2005 Aug; 53(2):261-6. PubMed ID: 16021121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
